PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Satellite Programs

TWILIGHT at Twilight: Assessing the Role of Monotherapy versus Dual Therapy - Examining Current Data

Evening Program

09/26/2019 18:30:00 09/26/2019 20:00:00 TWILIGHT at Twilight: Assessing the Role of Monotherapy versus Dual Therapy - Examining Current Data TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Evening Program

Thursday, September 26, 2019
Reception: 6:00 pm  | 
Program: 6:30 pm-8:00 pm
San Francisco Marriott Marquis, Yerba Buena Ballroom 9, Lower B2 Level

TWILIGHT at Twilight: Assessing the Role of Monotherapy versus Dual Therapy - Examining Current Data

TWILIGHT at Twilight: Assessing the Role of Monotherapy versus Dual Therapy - Examining Current Data

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from AstraZeneca

Chairs  

C. Michael Gibson, MS, MD

Beth Israel Deaconess Medical Center

Boston, MA

 

Roxana Mehran, MD

Icahn School of Medicine at Mount Sinai

New York, NY

Faculty  

Dominic J. Angiolillo, MD

Brigham and Women’s Hospital

Boston, MA

 

Usman Baber, MD

Mount Sinai Medical Center

New York, NY

 

David J. Cohen, MD

Saint Luke's Mid America Heart Institute

Kansas City, MO

 

Kurt Huber, MD

Wilhelminenhospital

Vienna, Austria

 

Shamir R. Mehta, MD, MSc

Hamilton Health Sciences

Hamilton, Canada

 

David J. Moliterno, MD

University of Kentucky

Lexington, KY

 

Sunil V. Rao, MD

Duke University Medical Center

Durham, NC

 

Marco Valgimigli, MD, PhD

University of Bern

Bern, Switzerland

 

Pascal Vranckx, MD, PhD

Hartcentrum Hasselt

Hasselt, Belgium

Agenda

6:30 pm

Welcome and Introductions

C. Michael Gibson, Roxana Mehran

6:32 pm

TWILIGHT: A Deep Dive

Usman Baber

6:47 pm

Transitioning to Monotherapy in Patients After PCI

Pascal Vranckx

6:55 pm

Reconciling Adjudicated Data Within a Global Trial

Marco Valgimigli

7:03 pm

Take Home for Clinicians

C. Michael Gibson

7:11 pm

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

7:19 pm

COMPLETE Trial: Focus on STEMI and MVD

Shamir R. Mehta

7:27 pm

Take Home for Clinicians: DM and STEMI

Dominic J. Angiolillo

7:35 pm

Panel Discussion: Assessing the Role of Potent P2Y12 Inhibition

7:50 pm

Final Words

Roxana Mehran

8:00 pm

Adjourn